1,681 top medical experts on Balloon Angioplasty across 50 countries and 47 U.S. states, including 1,646 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Balloon Angioplasty: Use of a balloon catheter for dilation of an occluded artery. It is used in treatment of arterial occlusive diseases, including renal artery stenosis and arterial occlusions in the leg. For the specific technique of balloon dilation in coronary arteries, angioplasty, balloon, coronary is available.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Angioplasty (2,959) and Narrower Categories: Coronary Balloon Angioplasty (4,022), Laser-Assisted Balloon Angioplasty (208).


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Jaff, Michael R   Internal Medicine   Google Publications
    Harvard Medical School, Boston, MA, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $5,372.3, including $5,250 from  Silk Road Medical, Inc.
    Subjects: Angioplasty, Balloon; Peripheral Arterial Disease; Coated Materials, Biocompatible; Cardiovascular Agents; Paclitaxel; Vascular Access Devices
    Categories: Therapy; Administration & Dosage; Instrumentation; Economics; Surgery; Methods
    Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. (2015)
    Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. (2010)

  2. Scheinert, Dierk     Google Publications
    Department of Angiology, Leipzig Heart Center, Leipzig, Germany.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Angioplasty, Balloon; Peripheral Arterial Disease; Paclitaxel; Coated Materials, Biocompatible; Cardiovascular Agents; Vascular Access Devices
    Categories: Therapy; Administration & Dosage; Instrumentation; Methods; Surgery; Blood Supply
    Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. (2015)
    Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. (2010)

  3. Laird, John R   Cardiovascular Disease   Google Publications
    Adventist Heart and Vascular Institute, St. Helena, California.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medical school: Albany Medical College of Union University (MD, 1984)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 62.3/100
    Disclosed payments in 2021 from 50 biomedical companies, totalling $2,702.82, including $1,787.43 from  BOSTON SCIENTIFIC CORPORATION
    Subjects: Angioplasty, Balloon; Peripheral Arterial Disease; Stents; Coated Materials, Biocompatible; Arterial Occlusive Diseases; Femoral Artery
    Categories: Therapy; Instrumentation; Administration & Dosage; Methods; Economics; Diagnostic Imaging
    Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. (2010)
    Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon. (2019)

  4. Ansel, Gary M   Interventional Cardiology   Google Publications
    Ohio Health, Riverside Methodist Hospital, Columbus, Ohio.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 76.1/100
    Disclosed payments in 2021 from 30 biomedical companies, totalling $55,969.57, including $24,869.5 from  Becton, Dickinson and Company
    Subjects: Angioplasty, Balloon; Peripheral Arterial Disease; Femoral Artery; Paclitaxel; Stents; Coated Materials, Biocompatible
    Categories: Therapy; Instrumentation; Administration & Dosage; Standards; Methods; Mortality
    Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. (2010)
    Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. (2011)

  5. Krishnan, Prakash   Interventional Cardiology   Google Publications
    The Mount Sinai Hospital, New York.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medical school: Other (MD, 1997)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 72.4/100
    Disclosed payments in 2021 from 132 biomedical companies, totalling $11,036.64, including $4,909.39 from  Medtronic, Inc.
    Subjects: Angioplasty, Balloon; Paclitaxel; Peripheral Arterial Disease; Cardiovascular Agents; Coated Materials, Biocompatible; Vascular Access Devices
    Categories: Administration & Dosage; Therapy; Instrumentation; Diagnostic Imaging; Adverse Effects; Chemistry
    Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. (2015)
    Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA. (2015)

  6. Brodmann, Marianne     Google Publications
    Angiologische Abteilung, LKH-Universitäts-Klinikum Graz, Austria M.B..
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Subjects: Angioplasty, Balloon; Peripheral Arterial Disease; Coated Materials, Biocompatible; Paclitaxel; Cardiovascular Agents; Vascular Access Devices
    Categories: Therapy; Administration & Dosage; Instrumentation; Surgery; Blood Supply; Methods
    Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. (2015)
    Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon. (2019)

  7. Rosenfield, Kenneth A   Cardiovascular Disease   Google Publications
    Vascular Medicine and Intervention, Massachusetts General Hospital, Boston, Massachusetts. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Medical school: University of Massachusetts Medical School (MD, 1982)
    Medicare Accepted
    Disclosed payments in 2021 from 30 biomedical companies, totalling $337,995.93, including $241,020 from  Imperative Care, Inc
    Subjects: Angioplasty, Balloon; Peripheral Arterial Disease; Paclitaxel; Coated Materials, Biocompatible; Cardiovascular Agents; Stents
    Categories: Instrumentation; Therapy; Administration & Dosage; Surgery; Economics; Standards
    Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. (2015)
    The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. (2014)

  8. Tepe, Gunnar     Google Publications
    Department of Diagnostic and Interventional Radiology, Klinikum Rosenheim, Rosenheim, Germany.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Angioplasty, Balloon; Peripheral Arterial Disease; Cardiovascular Agents; Coated Materials, Biocompatible; Paclitaxel; Vascular Access Devices
    Categories: Therapy; Administration & Dosage; Instrumentation; Methods; Physiopathology; Blood Supply
    Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon. (2019)
    The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. (2014)

  9. Shishehbor, Mehdi H   Cardiovascular Disease   Google Publications
    Harrington Heart & Vascular Institute, University Hospital Cleveland Medical Center, Cleveland, OH, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medical school: Other (MD, 1999)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 88/100
    Disclosed payments in 2021 from 57 biomedical companies, totalling $24,490.64, including $13,827.53 from  Medtronic, Inc.
    Subjects: Angioplasty, Balloon; Peripheral Arterial Disease; Coated Materials, Biocompatible; Cardiovascular Agents; Paclitaxel; Vascular Access Devices
    Categories: Therapy; Economics; Instrumentation; Administration & Dosage; Surgery; Blood Supply
    Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon. (2019)
    The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes. (2020)

  10. Schermerhorn, Marc L   Vascular Surgery   Google Publications
    Harvard Medical School, Boston, MA E.A.S., M.S., R.W.Y.. Top Hospital
    Physician  Highly Published  Review 
    Medical school: Georgetown University School of Medicine (MD, 1991)
    Medicare Accepted
    Disclosed payments in 2021 from 8 biomedical companies, totalling $641.35, including $436.63 from  Medtronic, Inc.
    Subjects: Angioplasty, Balloon; Stents; Femoral Artery; Lower Extremity; Peripheral Arterial Disease; Arterial Occlusive Diseases
    Categories: Therapy; Trends; Instrumentation; Administration & Dosage; Blood Supply; Methods
    Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft. (2011)
    Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease. (2012)

  11. Lyden, Sean P   Vascular Surgery  Google Publications
    Department of Vascular Surgery, Cleveland Clinic and Foundation, Cleveland, OH, USA.
    Physician  Clinical Trial  Review 
    Medical school: University of Cincinnati College of Medicine (MD, 1993)
    Medicare Accepted
    Disclosed payments in 2021 from 54 biomedical companies, totalling $39,875.67, including $21,192.63 from  Penumbra, Inc.
    Subjects: Angioplasty, Balloon; Peripheral Arterial Disease; Paclitaxel; Cardiovascular Agents; Coated Materials, Biocompatible; Data Analysis
    Categories: Administration & Dosage; Mortality; Therapy; Chemistry
    Mortality and Paclitaxel-Coated Devices: An Individual Patient Data Meta-Analysis. (2020)
    Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies. (2017)

  12. Katzen, Barry T   Diagnostic Radiology  Google Publications
    Department of Interventional Radiology, Miami Cardiac & Vascular Institute, Baptist Health South Florida, Miami, FL; Department of Interventional Radiology, Florida International University Herbert Wertheim College of Medicine, Miami, FL.
    Physician  Highly Cited  Clinical Trial  Case Reports 
    Medical school: University of Miami, Lm Miller School of Medicine (MD, 1970)
    Medicare Accepted
    Disclosed payments in 2021 from 19 biomedical companies, totalling $22,633.01, including $22,460.54 from  W. L. Gore & Associates, Inc.
    Subjects: Angioplasty, Balloon; Arterial Occlusive Diseases; Peripheral Arterial Disease; Alloys; Centers for Medicare and Medicaid Services, U.S.; Coated Materials, Biocompatible
    Categories: Economics; Therapy; Drug Effects; Instrumentation; Surgery
    Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. (2010)
    Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. (2012)

  13. Goldstein, Jeffrey A   Interventional Cardiology  Google Publications
    Division of Cardiology, Prairie Heart Institute, Springfield, Illinois.
    Physician  Highly Cited  Clinical Trial  Case Reports 
    Medical school: Saint Louis University School of Medicine (MD, 1996)
    Medicare MIPS (Merit-based Incentive Payment System) rating: 71.8/100
    Disclosed payments in 2021 from 16 biomedical companies, totalling $561.45, including $361.8 from  Medtronic, Inc.
    Subjects: Angioplasty, Balloon; Alloys; Arterial Occlusive Diseases; Stents; Aortic Aneurysm, Thoracic; Blood Vessel Prosthesis Implantation
    Categories: Therapy; Methods; Drug Effects; Instrumentation; Surgery
    Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. (2010)
    Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. (2012)

  14. Ouriel, Kenneth   Vascular Surgery   Google Publications
    Syntactx, New York.
    Physician  Clinical Trial  Review 
    Disclosed payments in 2021 from 4 biomedical companies, totalling $5,727.5, including $5,727.5 from  Medtronic, Inc.
    Subjects: Angioplasty, Balloon; Cardiovascular Agents; Paclitaxel; Coated Materials, Biocompatible; Peripheral Arterial Disease; Vascular Access Devices
    Categories: Administration & Dosage; Instrumentation; Surgery; Therapy; Adverse Effects; Methods
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas. (2020)
    Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease. (2019)

  15. Kodali, Susheel K   Interventional Cardiology  Google Publications
    Department of Medicine, Division of Cardiology, Columbia University Medical Center/New York-Presbyterian Hospital, 177 Fort Washington Avenue, New York, NY 10032, USA.
    Physician  Case Reports 
    Medical school: Un of California, Irvine, College of Medicine (MD, 1998)
    Medicare Accepted
    Disclosed payments in 2021 from 61 biomedical companies, totalling $8,049.6, including $3,225.84 from  BOSTON SCIENTIFIC CORPORATION
    Subjects: Angioplasty, Balloon; Heart Valve Prosthesis Implantation; Aortic Valve Stenosis; Aortic Rupture; Aortic Valve; Cardiac Catheterization
    Categories: Prevention & Control; Surgery; Adverse Effects; Therapy; Etiology; Methods
    Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. (2013)
    Efficacy and safety of postdilatation to reduce paravalvular regurgitation during balloon-expandable transcatheter aortic valve replacement. (2013)

  16. Katsanos, Konstantinos   Google Publications
    General University Hospital of Patras, Rio, Greece.
    Scientist  Highly Cited  Highly Published  Clinical Trial  Case Reports  Review 
    Subjects: Angioplasty, Balloon; Peripheral Arterial Disease; Drug-Eluting Stents; Paclitaxel; Cardiovascular Agents; Vascular Access Devices
    Categories: Therapy; Instrumentation; Administration & Dosage; Methods; Adverse Effects; Blood Supply
    Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2018)
    Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2020)

  17. Spiliopoulos, Stavros     Google Publications
    Attikon University Hospital, Athens, Greece.
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Subjects: Angioplasty, Balloon; Peripheral Arterial Disease; Drug-Eluting Stents; Paclitaxel; Cardiovascular Agents; Coated Materials, Biocompatible
    Categories: Therapy; Instrumentation; Administration & Dosage; Methods; Surgery; Adverse Effects
    Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2018)
    Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2020)

  18. Kapadia, Samir R   Cardiovascular Disease  Google Publications
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, USA.
    Physician  Case Reports 
    Medical school: Other (MD, 1990)
    Medicare Accepted
    Disclosed payments in 2021 from 14 biomedical companies, totalling $2,564.31, including $1,491 from  Ancora Heart, Inc.
    Subjects: Angioplasty, Balloon; Stents; Aortic Rupture; Aortic Valve Stenosis; Cardiac Catheterization; Carotid Stenosis
    Categories: Therapy; Adverse Effects; Etiology; Instrumentation; Radiotherapy
    Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. (2013)
    Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials. (2011)

  19. Forbes, Thomas J   Pediatric Cardiology  Google Publications
    Childrens Hospital of Michigan, Detroit, Michigan.
    Physician  Case Reports  Review 
    Disclosed payments in 2021 from 144 biomedical companies, totalling $145,774.45, including $114,441.81 from  Abbott Laboratories
    Subjects: Angioplasty, Balloon; Stents; Aortic Coarctation; Blood Vessel Prosthesis Implantation; Cardiac Catheterization; Femoral Artery
    Categories: Therapy; Surgery; Adverse Effects; Instrumentation; Methods
    Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). (2011)
    Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries. (2019)

  20. Patel, Manesh R   Internal Medicine   Google Publications
    Division of Cardiology Duke University School of Medicine Durham NC. Top Hospital
    Physician  Clinical Trial 
    Medical school: Emory University School of Medicine (MD, 1997)
    Medicare Accepted
    Disclosed payments in 2021 from 14 biomedical companies, totalling $25,513.28, including $13,285 from  Janssen Pharmaceuticals, Inc
    Subjects: Angioplasty, Balloon; Peripheral Arterial Disease; Amputation; Coated Materials, Biocompatible; Drug-Eluting Stents; Femoral Artery
    Categories: Methods; Therapy; Statistics & Numerical Data; Surgery; Instrumentation; Pharmacology
    Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. (2011)
    Survival and Causes of Death Among Veterans With Lower Extremity Revascularization With Paclitaxel-Coated Devices: Insights From the Veterans Health Administration. (2021)

Note:
  1. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);